Skip to Content Facebook Feature Image

Sustainable travel is contributing to the fight against illegal wildlife trade for global biodiversity protection

Business

Sustainable travel is contributing to the fight against illegal wildlife trade for global biodiversity protection
Business

Business

Sustainable travel is contributing to the fight against illegal wildlife trade for global biodiversity protection

2025-06-18 18:06 Last Updated At:18:25

BEIJING, June 18, 2025 /PRNewswire/ -- As one of the world's largest industries representing 10% of the global economy, travel and tourism has become an integral part of modern lifestyle. However, unsustainable travel practices, including the consumption of Illegal wildlife products, are putting immense pressure on ecosystems and accelerating biodiversity loss.

Tourism also contributes significantly to climate change, responsible for an estimated 6.5% of global greenhouse gas emissions in 2023. In ecologically sensitive areas, frequent human activities can lead to habitat destruction, environmental pollution and disturbance of wildlife. According to the World Wide Fund for Nature (WWF)'s Living Planet Report 2024, there has been a 73% decline in the average size of monitored wildlife populations over just 50 years between 1970 and 2020.

Sustainable tourism, as defined by the UN Environment Program and the UN World Tourism Organization, is "tourism that takes full account of its current and future economic, social and environmental impacts, addressing the needs of visitors, the industry, the environment and host communities."In China, a shift towards sustainable travel is emerging as a powerful way to counter the  risks from global climate change and biodiversity loss.

The country banned the domestic ivory trade from 2018, however, outbound travelers remain exposed to illegal wildlife markets abroad, such as in Southeast Asia and Africa. User-generated content and local tour guides are among the major sources shaping tourist decisions, and in some cases, directing them to markets that sell illegal wildlife products. Influencing travel behaviours is increasingly important for global conservation.

Stakeholders in China's tourism sector are working to mainstream sustainability. One initiative, the Sustainable Travel Alliance (STA), launched by WWF China in 2020, has brought together 50 member companies by 2025. These companies are committed to:

  • Protecting wildlife and natural habitats, refusing illegal wildlife products.
  • Saving resources and minimizing food waste.
  • Reducing the impact of plastic waste on biodiversity.

To equip tour operators with tools for promoting sustainable travel, WWF China and its partners have trained more than 1,500 frontline staff, while also supporting businesses in launching their own sustainability initiatives. A set of Sustainable Travel Guidelines tailored for hotels, travellers, and travel agencies developed by WWF China also offers practical, easy-to-implement recommendations to support responsible tourism practices at every stage of a journey.

On the traveler side, digital outreach plays a critical role. Building on behavioral insights regarding travelers' decision-making mechanism, WWF China has designed targeted social marketing campaigns to deliver customized messages encouraging sustainable travel and discouraging the purchase and transportation of illegal wildlife products, serving as a reminder before their outbound travel. These campaigns use data-driven segmentation via social media platforms, reaching the right audience at the right time and collecting digital pledges to raise awareness of supporting sustainable travel.

At physical touchpoints, such as airports, train stations, boarding passes, and in-flight media, WWF's public service announcements further reinforce the message to practice sustainable travel and refuse illegal wildlife products.

Regionally, WWF China and its partners have also initiated dialogues across China, Thailand and Viet Nam, emphasizing cross-border cooperation in reducing wildlife trafficking linked to tourism, while exploring innovative approaches of the application of Artificial Intelligence (AI) for wildlife conservation, advancing low-carbon hotel initiatives, and employing Environmental, Social and Governance (ESG) standards to encourage responsible travel behaviors.

Biodiversity underpins the health of our economies and societies, yet it is under threat. From elephant ranges in Africa to sea turtle nesting beaches in the Pacific, what we practice today is what travelers may still witness tomorrow.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Sustainable travel is contributing to the fight against illegal wildlife trade for global biodiversity protection

Sustainable travel is contributing to the fight against illegal wildlife trade for global biodiversity protection

Sustainable travel is contributing to the fight against illegal wildlife trade for global biodiversity protection

Sustainable travel is contributing to the fight against illegal wildlife trade for global biodiversity protection

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors

Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer

Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.

"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."

Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.

 

 

To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.

Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.

"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."

About Alamar Biosciences, Inc. 
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Recommended Articles